Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

    Press Releases | January 31, 2024 | OPEN Health

    OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

    Clinical trials explained: Why imagery matters…

    White Papers and Resources | January 29, 2024 | Cuttsy + Cuttsy

    Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

    Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

    Videos and Podcasts | January 25, 2024 | Impetus Digital

    In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

    Clinical trials explained: Why health literacy matters…

    White Papers and Resources | January 25, 2024 | Cuttsy + Cuttsy

    Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...

    ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

    Press Releases | January 25, 2024 | Oxford PharmaGenesis

    Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies.

    Inside Mednet’s Writing Academy: How do you mentor excellence?

    White Papers and Resources | January 24, 2024 | Mednet

    Medical Writer, Tayyibah Ali looks at how we mentor excellence within our team

    We are EatMoreFruit

    Videos and Podcasts | January 23, 2024 | EatMoreFruit

    Welcome to EatMoreFruit - We are a London-based top 10 independent healthcare communications agency. PR, digital, creative & commercial strategies for innovators in health, pharma and wellbeing.

    Patient Advocate Engagement: A Customer Story

    White Papers and Resources | January 22, 2024 | Impetus Digital

    Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

    OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

    Press Releases | January 22, 2024 | OPEN Health

    OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

    Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

    Videos and Podcasts | January 18, 2024 | Impetus Digital

    In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....